Albert Bourla, Pfizer CEO (Gian Ehrenzeller/Keystone via AP Images)
Pfizer earns long-awaited full FDA nod for Covid-19 vaccine, a hopeful aid in US campaign
The FDA on Monday announced its full approval for Pfizer and BioNTech’s mRNA-based Covid-19 vaccine for individuals 16 and older, potentially …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
